XML 16 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statement of Stockholders' Equity (unaudited) - 9 months ended Jun. 30, 2018 - USD ($)
Total
Common stock issued for cash at $5.25 per share
Common Stock
Common Stock
Common stock issued for cash at $5.25 per share
Additional Paid-In Capital
Additional Paid-In Capital
Common stock issued for cash at $5.25 per share
Accumulated Other Comprehensive Income (loss)
Accumulated Deficit
Non-controlling Interest
Beginning Balance, Amount at Sep. 30, 2017 $ 80,867,162   $ 167,155   $ 514,037,301   $ 33,232 $ (432,815,338) $ (555,188)
Beginning Balance, Shares at Sep. 30, 2017     74,785,426            
Stock-based compensation 5,818,119       5,818,119        
Exercise of stock options, Amount $ 1,032,058   $ 283   1,031,775        
Exercise of stock options, Shares 283,627   283,627            
Exercise of warrants, Amount $ 1,237,430   $ 289   1,237,141        
Exercise of warrants, Shares     288,473            
Common stock- Restricted Stock Units vesting, Amount (54,668)   $ 997   (55,665)        
Common stock- Restricted Stock Units vesting, Shares     997,125            
Stock issuances   $ 56,585,035   $ 11,500   $ 56,573,535      
Stock issuances, Shares       11,500,000          
Foreign currency translation adjustments (36,570)           (36,570)    
Net loss for the nine months ended June 30, 2018 (43,689,207)             (43,689,207)  
Ending Balance, Amount at Jun. 30, 2018 $ 101,759,359   $ 180,224   $ 578,642,206   $ (3,338) $ (476,504,545) $ (555,188)
Ending Balance, Shares at Jun. 30, 2018     87,854,651